Practice parameters for the prevention of venous thromboembolism

Diseases of the Colon and Rectum

Volumn 43, Issue 8, 2000, Pages 1037-1046

  Denstman, F ^a   Lowry, A ^a   Vernava, A ^a   Burnstein, M ^a   Fazio, V ^a   Glennon, E ^a   Hicks, T ^a   Hyman, N ^a   Kerner, B ^a   Kilkenny, J ^a   Moore, R ^a   Oliver, G ^a   Peters, W ^a   Ross, T ^a   Savoca, P ^a   Senatore, P ^a   Simmang, C ^a   Wong, W D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

DEEP VEIN THROMBOSIS; DEVICE; HEPARINIZATION; HUMAN; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS;

EID: 0033892748     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02236547     Document Type: Review

References (54)

1. Prevention of venous thromboembolism
2. Prophylaxis of venous thromboembolism: An overview
3. Prophylaxis of deep venous thrombosis in colorectal surgery
4. Postoperative thromboembolism after day-case herniorrhaphy
5. The risk of thromboembolism in patients undergoing colorectal surgery
6. The clinical course of pulmonary embolism
7. Venous thromboembolism, risk factors and prophylaxis
8. Risk factors for venous thrombosis: Prevalence, risk, and interaction
9. A population-based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism: The Worchester DVT study
10. Prevention of venous thrombosis and pulmonary embolism
11. The epidemiology, pathogenesis, and natural history of venous thrombosis
12. Venous thrombosis of the legs and cancer. Evaluation of risk factors of venous thrombosis in the medical environment
13. Treatment of thrombotic disorders in cancer patients
14. Hemostatic alterations in inflammatory bowel disease
15. High risk of cerebral-vein thrombosis in carriers of prothrombin-gene mutation and in users of oral contraceptives
16. Oral contraceptives and postoperative venous thrombosis
17. Estrogen replacement therapy and the risk of venous thrombosis
18. Tamoxifen in the treatment of breast cancer
19. Prevention of venous thromboembolism
20. Clinical assessment of venous thromboembolic risk in surgical patients
21. Intermittent pneumatic calf compression for prevention of deep venous thrombosis in general abdominal surgery
22. Blood flow augmentation of intermittent pneumatic compression systems used for the prevention of deep venous thrombosis prior to surgery
23. Intermittent sequential pneumatic compression of the legs and thromboembolism-deterrent stockings in the prevention of postoperative deep venous thrombosis
24. Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis
25. The origin of lower extremity deep vein thrombi in acute venous thrombosis
26. Intermittent sequential compression of the lower limbs prevents venous stasis in laparoscopic and conventional colorectal surgery
27. Effect of optimization of hemodynamics on fibrinolytic activity and antithrombotic efficacy of external pneumatic calf compression
28. The logistic problems encountered in the multicenter trial of low-dose heparin prophylaxis
29. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Reappraisal of results of international multicentre trial
30. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin
31. Prevention of venous thrombo-embolism in general surgical patients. Results of meta-analysis
32. Prevention of venous thromboembolism
33. Risk factors for bleeding in major abdominal surgery using heparin prophylaxis
34. Heparin and low-molecular-weight heparin
35. Heparin-associated thrombocytopenia
36. Heparin-induced thrombocytopenia, thrombosis and hemorrhage
37. Heparin-induced thrombocytopenia and thrombosis
38. Low-molecular-weight heparins
39. A comparative trial of a low-molecular-weight (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery
40. Comparison of low-molecular-weight heparin (LMWH) to low dose heparin (LDH) in the prevention of venous thromboembolism (VTE) in patients undergoing colorectal surgery
41. Randomized, controlled trial of low-molecular-weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients
42. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blinded randomized multicentre trial with venographic assessment
43. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: Update of previous meta-analyses
44. Efficacy and safety of low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial
45. Economic analysis of low-dose heparin vs the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery
46. Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty
47. Serious spinal cord injury due to haemaoyelia caused by spinal anaesthesia in a patient treated with low-dose heparin
48. Low molecular weight heparin: Biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management
49. The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery
50. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement